Hemophilia can cause disability and even early death. There are many causes of hemophilia, most of which are genetic and a few are due to mutations of healthy genes into disease genes.

Although hemophilia is rare, it is very dangerous because it cannot be completely treated, and has the potential to cause disability and even early death for the patient. Therefore, screening and early detection of the disease are important in minimizing the danger of this disease.

Hemophilia is a dangerous genetic disease that not only threatens the patient's life but also increases the mental and economic burden on the family and society. Hemophilia gene mutation is the cause of hemophilia.

Hemophilia in children is common in boys over 3 years old, mainly due to genetic causes. If not treated promptly, the disease can easily cause death.

Hemophilia, technically known as hemophilia, is a condition in which the blood is unable to clot normally. This makes the patient very susceptible to bleeding, bleeding more than normal, sometimes life-threatening. The disease is genetic so there is no cure. Treatment is mainly to support the ability to clot blood as well as prevent bleeding. The following are notes on the treatment of hemophilia and ways to prevent bleeding that patients should know to have a life of integration with everyone around them.

Hemophilia is a rare blood clotting disorder in which the patient's blood often lacks one or more clotting factors, making it difficult to stop bleeding. This is especially dangerous for people with Hemophilia, especially in cases of trauma, internal bleeding, etc.

Hemophilia is an X-linked hereditary bleeding disorder caused by a deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B) leading to thromboplastin production disorder that slows blood clotting. The incidence of Hemophilia is about 20/100,000 males, 80-85% of patients are Hemophilia A.

Hemophilia is an X-linked hereditary bleeding disorder caused by a deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B) leading to thromboplastin production disorder that slows blood clotting. The incidence of Hemophilia is about 20/100,000 males, 80-85% of patients are Hemophilia A.

Hemophilia is an X-linked hereditary bleeding disorder caused by reduced or abnormal function of factor VIII (Hemophilia A) or factor IX (Hemophilia). In Vietnam, it is estimated that there are 6,000 patients and 30,000 carriers. Treatment of Hemophilia is to infuse deficient factor VIII or IX into the patient.

Hemophilia is a genetic disease that leaves many serious sequelae, even causing early death. However, the disease has a special genetic mechanism, so it is possible to stop the disease gene from being passed on to the next generation through prenatal diagnostic tests.